By CNN –
The hunt for cancer-combatting antibodies normally relies upon human lab scientists combing through vast amounts of data. LabGenius’ automated AI robotic system has disrupted that process. Using machine learning, their model has pushed through the human cognition barrier to design, conduct and learn from its own experiments, allowing the company to create potential antibodies that can be used on diseases like cancer far more efficiently.
